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Abstract. The enzyme myo-Inositol oxygenase (MIOX) is 
also termed ALDRL6. It is a kidney‑specific member of the 
aldo‑keto reductase family. MIOX catalyzes the first reaction 
involved in the myo‑inositol metabolism signaling pathway 
and is fully expressed in mammalian tissues. MIOX cata-
lyzes the oxidative cleavage of myo‑Inositol and its epimer, 
D-chiro-Inositol to D-glucuronate. The dioxygen-dependent 
cleavage of the C6 and C1 bond in myo‑Inositol is achieved 
by utilizing the Fe2+/Fe3+ binuclear iron center of MIOX. 
This enzyme has also been implicated in the complications 
of diabetes, including diabetic nephropathy. The MIOX 
gene was amplified with reverse transcription‑polymerase 
chain reaction from baboon tissue samples, and the product 
was cloned and sequenced. MIOX expression in the baboon 
kidney is described in the present study. The percentages of 
nucleotide and amino acid similarities between baboons and 
humans were 95 and 96%, respectively. The MIOX protein of 
the baboon may be structurally identical to that of humans. 
Furthermore, the evolutionary changes, which have affected 
these sequences, have resulted from purifying forces.
Introduction
In mammalian cells, the only pathway for inositol breakdown is 
via myo-Inositol oxygenase (MIOX) (1). MIOX is a non-heme 
iron enzyme, which performs the conversion of myo‑Inositol to 
glucuronic acid, the first committed step in myo‑Inositol catabo-
lism (2,3). The reaction involves oxidative cleavage of the bond 
between C6 and C1 to produce D‑glucuronic acid. D‑glucuronic 
acid is successively converted to L-gulonate, 3-keto-L-gulonate, 
L-xylulose, xylitol, D-xylulose and D-xylulose-5-phosphate, 
which then enters the pentose phosphate cycle (4). MIOX 
is predominantly expressed in the renal tubules, but is also 
observed at lower levels in extra‑renal tissues, where diabetic 
complications are widely shown (3). Altered inositol metabo-
lism is implicated in a number of diabetic complications, 
including cataracts, nephropathy, retinopathy and neuropathy. 
MIOX enzymatic activity is proportional to its serum glucose 
concentration (5). In addition, there is evidence that a polymor-
phism (rs761745) in the promoter region of the MIOX gene is 
associated with the progress of type 1 diabetes mellitus (1,6).
Molecular cloning of the myo‑inositol oxygenase 
gene from the kidney of baboons
RAFAEL GONZÁLEZ‑ÁLVAREZ1,  DIANA CRISTINA PÉREZ‑IBAVE2,  MARÍA LOURDES GARZA‑RODRÍGUEZ3, 
ÁNGEL LUGO‑TRAMPE4,  IVÁN DELGADO‑ENCISO5,  MARÍA ELIZABETH TEJERO‑BARRERA6,  
LAURA ELIA MARTÍNEZ‑DE‑VILLARREAL7,  RAQUEL GARZA‑GUAJARDO8,  
MARÍA MARISELA SÁNCHEZ‑CHAPARRO7,  GABRIEL RUIZ‑AYMA9, 
ORALIA BARBOZA‑QUINTANA8,  HUGO ALBERTO BARRERA‑SALDAÑA3, 
MARÍA DEL REFUGIO ROCHA‑PIZAÑA10  and  IRÁM PABLO RODRÍGUEZ‑SÁNCHEZ7
1Facultad de Medicina, Universidad Autónoma de Guadalajara, Zapopan, Jalisco 45129; 2Servicio de Oncología, 
Universidad Autónoma de Nuevo León, Centro Universitario Contra el Cáncer, Hospital Universitario ‘Dr José Eleuterio 
González’; 3Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo 
León, Monterrey, Nuevo León 64460; 4Centro Mesoamericano de Estudios en Salud Pública y Desastres (CEMESAD, 
Nodo Tapachula), Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas 29076; 5Facultad de Medicina, Universidad de 
Colima, Colima 28040; 6Instituto Nacional de Medicina Genómica (INMEGEN), Laboratorio Nutrigenética y Nutrigenómica, 
Tlalpan, Arenal Tepepan 14610; 7Departamento de Genética y Defectos Congénitos, Universidad Autónoma de Nuevo León, 
Centro Universitario Contra el Cáncer; 8Servicio de Anatomía Patológica y Citopatología, Universidad Autónoma de Nuevo 
León, Hospital Universitario ‘Dr José Eleuterio González’, Monterrey, Nuevo León 64460; 9Departamento de Ecología, 
Universidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, San Nicolás de los Garza, Nuevo León 66425; 
10Centro de Biotecnología‑FEMSA, Tecnológico de Monterrey Campus Monterrey, Monterrey, Nuevo León 64849, Mexico
Received January 3, 2017;  Accepted February 8, 2017
DOI: 10.3892/br.2017.973
Correspondence to: Professor Irám Pablo Rodríguez‑Sánchez, 
Departamento de Genética y Defectos Congénitos, Universidad 
Autónoma de Nuevo León, Centro Universitario Contra el 
Cáncer, Hospital Universitario ‘Dr. José Eleuterio González’, 
Avenida Gonzalitos s/n, Colonia Mitras Centro, Monterrey, Nuevo 
León 64460, Mexico
E-mail: iramrodriguez@gmail.com
Key words: animal models, gene expression, kidney, myo-inositol 
oxygenase, Old World monkey
GONZÁLEZ‑ÁLVAREZ et al:  MIOX FROM BABOON KIDNEY302
The structure of the MIOX gene has been characterized 
in humans and other mammals, including mice and rats, and 
MIOX sequences for cows, wild boars, dogs, orangutans, 
rhesus monkeys, common marmosets, bonobos, northern 
greater galagos, and Tasmanian devils are reported in 
GenBank (2,4,7).
In humans, the MIOX gene is located on chromosome 22 in 
band 22q13.3, and consists of a DNA coding sequence (CDS) 
of 858 nucleotides (nt) split by 11 introns (exon 1,15 nt; 
exon 2,81 nt; exon 3,81 nt; exon 4,163 nt; exon 5,68 nt; 
exon 6,110 nt; exon 7,68 nt, exon 8,50 nt; exon 9,113 nt; and 
exon 10,109 nt). The open reading frame (ORF) encodes 
a polypeptide of 285 amino acid residues with a mass of 
33.01 kDa (8).
Although the function of the MIOX enzyme in 
human physiology has been determined, there are few 
MIOX-associated studies (8). Currently, there are gaps in the 
genomic information of MIOX in experimental animal models; 
thus, characterizing the physiological differences between 
humans and other MIOX proteins is difficult. An animal 
model closely associated with humans was selected in the 
current study. The current study describes the gene encoding 
MIOX in the baboon (Papio hamadryas). It is hypothesized 
that the baboon is an ideal animal model due to the fact that 
baboons spontaneously develop type 1 and 2 diabetes, which is 
considered to be a physiological research advantage.
Materials and methods
Animal specimens and nucleic acid isolation from biological 
samples. Samples from three male baboons were collected 
from the following frozen archived tissues: Testis, kidney, 
heart, omental fat, skeletal muscle, pancreas, mononuclear 
cells, liver and hypothalamus. The samples were collected 
according to ethical guidelines reviewed by the Institutional 
Animal Care and Use Committee of the Texas Institute of 
Biomedical Research (TIBR) (San Antonio, TX, USA). The 
animals had been housed at the Southwest National Primate 
Research Center at TIBR and were sacrificed under humani-
tarian conditions. All of the baboons were housed together and 
fed ad libitum on standard low‑fat chow (15% Monkey Diet, 
8715; Harlan Teklad Labs, Houston, TX, USA).
Total RNA was isolated from the tissue samples using 
TRIzol reagent (Invitrogen; Thermo Fisher Scientific, 
Inc., Waltham, MA, USA), according to the manufac-
turer's instructions. The RNA samples were treated with 
DNaseI (Invitrogen; Thermo Fisher Scientific, Inc.) for 
10 min at 37˚C to remove any remainder of genomic DNA. 
The quality and integrity of the RNA were evaluated using 
standard spectrophotometric and electrophoretic methods, 
respectively.
Reverse transcription (RT) and polymerase chain reaction 
(PCR) amplification. The RT reactions were developed with 
1 µg total RNA using random primers and a high‑capacity 
cDNA RT kit (Applied Biosystems; Thermo Fisher Scientific, 
Inc.), according to the manufacturer's instructions. To 
amplify the baboon MIOX cDNA with PCR, 2X Taq PCR 
Master Mix (Qiagen, Inc., Valencia, CA, USA) was used, 5 µl 
synthesized cDNA served as the template, and 10 pM of each 
consensus primer (forward, 5'‑TATAGGAGCCTGGCTG 
AGGA‑3' and reverse, 5'‑CAGGCCTAGGTCCAGCAG‑3'), 
designed based on previously reported, highly conserved 
primate MIOX sequences with the online UniPrime2 
tool http://uniprime.batlab.eu (9). The complete MIOX CDS 
was amplified (based on the human MIOX gene sequence). 
The PCR thermal cycling program included initial 
denaturation at 94˚C for 3 min, followed by 28 cycles of 
denaturation at 94˚C for 30 sec, annealing at 59˚C for 35 sec, 
and elongation at 72˚C for 45 sec, with a final elongation 
at 72˚C for 6 min. Universal β-actin gene primers (Ambion; 
Thermo Fisher Scientific, Inc.) were used to amplify the 
positive control. All PCR amplification products were 
Table I. Primates MIO‑X sequences from NCBI GenBank.
Species (scientific name) mRNA accession no.
Apes
  Human (Homo sapiens) NM_017584.5
  Pygmy chimpanzee (Pan paniscus) XM_003811021.1
  Gorilla (Gorilla gorilla) XM_004063692.1
  Sumatran orangutan (Pongoa belii) NM_001131282.2
Old World monkeys
  Hamadryas baboon (Papio hamadryas) KP299165
  Olive baboon (Papioanubis) XM_003905754.1
  Gibbon (Noma scusleucogenys) XM_003281467.1
  Rhesus monkey (Macaca mulatta) XM_001116334.2
  Crab‑eating macaque XM_005566896.1
  (Macaca fascicularis)
New World monkeys
  Squirrel monkey XM_003932782.1
  (Saimiri boliviensis boliviensis)
Lemur (out-group)
  Galago (Otolemur garnettii) XM_003783084.1
Table II. Evolutionary forces that underlie the process of diver-
gence in the MIO-X primate genes.
Species dN dS P‑valuea
Human 0.0339 0.5298 0.0001
Pygmy chimpanzee 0.0347 0.5633 0.0001
Gorilla 0.0365 0.4986 0.0001
Sumatran orangutan 0.0348 0.4868 0.0001
Hamadryas baboon 0.0390 0.5404 0.0001
Olive baboon 0.0348 0.5344 0.0001
Gibbon 0.0330 0.4781 0.0001
Rhesus monkey 0.0366 0.5402 0.0001
Crab eating macaque 0.0339 0.5144 0.0001
Squirrel monkey 0.0434 0.4354 0.0001
afor purifying selection (dN<dS). dN, non‑synonymous substitution; 
dS, synonymous substitution.
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confirmed by electrophoresis in agarose gel (1%) at 75 V for 
35 min, stained with ethidium bromide and visualized under 
UV light. To visualize ethidium bromide‑stained DNA gels 
we used a transilluminator (an ultraviolet lightbox).
Molecular cloning and sequencing. The PCR products 
were cloned with the TOPO® XL PCR Cloning kit with the 
pCR®-XL-TOPO® 3.5 kb vector (Invitrogen; Thermo Fisher 
Scientific, Inc.). Electrocompetent Top 10 Escherichia 
coli cells (Invitrogen; Thermo Fisher Scientific, Inc.) were 
transformed with the ligation reactions, according to the 
manufacturer's instructions. The cloning products were 
sequenced with an ABI PRISM 3100 Genetic Analyzer 
(Applied Biosystems Life Technologies) using the universal 
M13 primers and BigDye® Terminator Cycle Sequencing 
Reagents (Applied Biosystems; Thermo Fisher Scientific, Inc.). 
The electropherograms were analyzed with the GeneStudio 
Pro tool (GeneStudio, Inc., Suwanee, GA, USA). The DNA 
sequences of the MIOX transcripts were used to deduce the 
amino acid sequences using the Transeq online softwa http:// 
www.ebi.ac.uk/Tools/st/emboss_transeq/ (10), and these were 
subsequently aligned with other MIOX sequences using the 
ClustalW program (11). All procedures were performed with 
three clones of each amplicon to exclude artifacts.
Phylogenetic analysis. The data obtained from the sequencing 
analysis were used as the target sequence in a Basic Local 
Alignment Search Tool search to determine the identity. The 
Figure 1. Alignment of human and baboon myo‑inositol oxygenase protein. Structurally conserved amino acids are indicated in green (lysine, K127); blue for 
histidine (H98, H123, H194 and H220); and yellow for aspartate (D124 and D253). Ten amino acid differences are shown in red.
Figure 2. Phylogenetic tree of myo‑inositol oxygenase coding sequences from various primates. The tree was constructed using MEGA version 6 with the 
neighbor‑joining method and a bootstrap analysis with 1,000 replications. The bootstrap values are indicated on the branches. The lineage‑specific clades 
represent the apes, Old World Monkeys, New World Monkeys and lemurs (out‑group).
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sequences were subsequently aligned using the ClustalW 
program http://www.ebi.ac.uk/Tools/msa/clustalw2 (11). 
The GenBank accession numbers of the sequences used in 
the current study are presented in Table I. A phylogenetic 
tree was constructed from the mRNA sequences using 
MEGA version 6 software (12) with the neighbor‑joining 
method (13) with 1,000 bootstrap replications (14). To 
identify the evolutionary forces underlying the divergence 
in the primate MIOX genes, the synonymous (dS; encoded 
amino acid does not change) and non‑synonymous (dN; the 
encoded amino acid changes) substitutions were quantified 
using the modified Nei‑Gojobori method (15), and the 
MIOX CDs from apes, Old World monkeys (OWMs) and 
New World monkeys (NWMs), with the lemur counterpart 
sequence as the out‑group. The hypothesis of positive or 
adaptive evolution (dN>dS), purifying selection (dN<dS) 
and neutrality (dN=dS) was then tested using a codon‑based 
Z test of selection (16), which is included in the MEGA 
version 6 software (12). P<0.05 was considered to indicate a 
statistically significant difference.
Results
Molecular biology. A single band of the expected size (858 bp) 
was amplified by RT‑PCR from renal tissue cDNA. This 
amplicon was not observed in the other tissue samples (testis, 
heart, omental fat, skeletal muscle, pancreas, mononuclear 
cells, liver or hypothalamus) that were analyzed. Thus, the 
MIOX transcript was only observed in the kidney. The novel 
sequence was deposited in the GenBank database (accession 
no. KP299165).
The nucleotide and amino acidic sequences of baboon 
MIOX were compared with their human counterparts. 
The percentage nucleotide similarity between the baboon 
and human genes was 95% and the percentage amino acid 
identity between the proteins was 96%. In total, 10 amino acid 
changes were identified between the two primate species. 
Thorsell et al (1) proposed a novel role for Lys127 (K127) in 
the crystallized human MIOX protein in controlling access to 
the diiron cluster. That position is conserved in the baboon 
enzyme as predicted from the ORF. In our previous study, it 
was found that, in the active site of the baboon MIOX enzyme, 
the diiron cluster is bound in a conserved crevice formed 
between α4, α5, α6, α7 and α8 (17). This represents a strictly 
conserved diiron cluster with a first coordination sphere of four 
histidines (H98, H123, H194 and H220) and two aspartates 
(D124 and D253) (1). All these positions are conserved in the 
baboon MIOX protein (Fig. 1).
Phylogenetic analysis. Apes, OWMs and NWMs demon-
strated a clear tendency toward purifying selection (dN<dS; 
P=0.0001). A screening test was performed using Fisher's 
exact test selection with the models of Nei‑Gojobori, 
Li‑Wu‑Luo, Pamilo‑Bianchi‑Li and Kumar. The same results 
were obtained with all the models used (Table II).
Statistical analysis. Statistical and mathematical calculations 
made in this work were performed using different 
algorithms of the MEGA software. Although there are many 
mathematical algorithms, none is better than another, they 
simply start from different assumptions. These algorithms 
are known and accepted among the expert community in 
the subject. The phylogenetic tree constructed from primate 
MIOX sequences (Fig. 2) shows four lineage‑specific 
clades, corresponding to apes, OWMs, NWMs and lemurs 
(out‑group). It supports the orthology within the primate 
MIOX genes. Bootstrap values are shown on the branches 
of the tree. Approaching results were obtained with other 
phylogenetic methods.
Discussion
Molecular biology. The MIOX sequence in baboons was 
observed to be highly similar to that of other apes. The 
preservation of exon‑intron limits and the lack of evident 
mutations indicate that the baboon MIOX gene is functional. 
To the best of our knowledge, this is the first study that reports 
the expression profile of the novel MIOX gene in different 
tissues from baboons. The results of the current study indi-
cate that, in baboons, the MIOX gene is only expressed in the 
kidney, while in humans, MIOX gene expression is observed 
in kidney and extrarenal tissue (3). To elucidate this differ-
ence, further studies are required, which include promoter 
alignment, bioinformatics analyses (in order to predict tran-
scriptional factor binding sites) and searching CpG islands 
that are susceptible to methylation. Conservation of the 
structural amino acid (lysine 127), histidines (98, 123, 194 
and 220) and aspartates (124 and 253) (1), suggests that the 
three‑dimensional shape may be identical in baboon and 
human MIOX protein (Fig. 1). Kidney expression in the two 
species suggests that the machinery, which regulates gene 
expression is similar in humans and baboons. In addition, 
it indicates that the MIOX gene may exert a similar physi-
ological impact. However, further studies under different 
physiological conditions, such as insulin resistance, diabetes, 
obesity, fasting or other conditions associated with metabolic 
syndrome, are required. 
Phylogenetic analysis. Positive selection (dN>dS) means that 
non‑synonymous substitutions are functional and profitable 
to the organism, and provide an evolutionary benefit. While 
purifying selection (dN<dS) implies that evolutionary pressure 
eases off. The dN and dS rates were estimated in the present 
study and it was found that the evolutionary force that acts is 
purifying selection (Table II). Thus, it was hypothesized that 
purifying selection is an indication that the MIOX gene is func-
tional in the studied species, as functional family genes fit this 
hypothesis. In conclusion, only one MIOX gene was found for 
baboons and splicing variants were not detected. Furthermore, 
MIOX gene expression was only identified in the kidney. The 
dN and dS rates conclusively demonstrated that MIOX genes 
are included in the hypothesis of purifying selection.
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